Search - tctmd.com

Displaying 1 - 20 of 53

Sort: Relevancy | Date

News Daily News

Lp(a) Linked to 30-Year CVD Risk in Healthy Women

Michael O'Riordan

January 09, 2026

News Daily News

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Michael O'Riordan

December 12, 2025

News Daily News

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

L.A. McKeown

November 04, 2025

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Michael O'Riordan

May 14, 2025

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

News Opinion CV Team Dispatch

September 2023 News Roundup

L.A. McKeown

September 01, 2023

News Daily News

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Michael O'Riordan

July 25, 2023

News Daily News

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Michael O'Riordan

July 07, 2023

News Conference News AHA 2022

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Michael O'Riordan

November 06, 2022

News Daily News

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Michael O'Riordan

October 03, 2022

News Conference News TCT 2022

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Shelley Wood

September 22, 2022

News Conference News EAS 2022

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

Michael O'Riordan

May 24, 2022

News Conference News ACC 2022

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

Michael O'Riordan

April 03, 2022

News Conference News ACC 2021

For Younger MI Survivors, Stress Boosts Adverse Outcomes

Caitlin E. Cox

May 13, 2021

News Daily News

Tocilizumab Improves Myocardial Salvage After STEMI: ASSAIL-MI

Michael O'Riordan

April 12, 2021

News Conference News AHA 2020

Childhood Stress, Trauma Linked to Worse Outcomes After Early MI

L.A. McKeown

November 16, 2020

News Conference News TCT 2020

Microclots Seen on OCT and Autopsy Can Inform COVID-19 Diagnostics, Care

L.A. McKeown

October 26, 2020

News Daily News

Thrombus Burden Greater in STEMI Patients With COVID-19

Michael O'Riordan

July 20, 2020

News Conference News SCAI 2020

Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data

Caitlin E. Cox

May 15, 2020

News Features

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

Caitlin E. Cox

April 23, 2020

Advertisement

Lp(a) Linked to 30-Year CVD Risk in Healthy Women

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

September 2023 News Roundup

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

For Younger MI Survivors, Stress Boosts Adverse Outcomes

Tocilizumab Improves Myocardial Salvage After STEMI: ASSAIL-MI

Childhood Stress, Trauma Linked to Worse Outcomes After Early MI

Microclots Seen on OCT and Autopsy Can Inform COVID-19 Diagnostics, Care

Thrombus Burden Greater in STEMI Patients With COVID-19

Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content